Title:
NOVEL HETEROCYCLIC DERIVATIVE COMPOUND AND USE THEREOF
Document Type and Number:
WIPO Patent Application WO/2018/004258
Kind Code:
A1
Abstract:
The present invention relates to a novel heterocyclic derivative compound and a use thereof and, more particularly, to a novel heterocyclic derivative compound having selective inhibitory activity against a fibroblast growth factor receptor (FGFR), and a pharmaceutical composition comprising the same for preventing or treating various diseases associated with the FGFR.
Inventors:
LEE MOON SUB (KR)
BYUN EUN YOUNG (KR)
KIM JI SOOK (KR)
KIM WON JEOUNG (KR)
KIM NAM DU (KR)
JUNG SEUNG HYUN (KR)
AHN YOUNG GIL (KR)
BYUN EUN YOUNG (KR)
KIM JI SOOK (KR)
KIM WON JEOUNG (KR)
KIM NAM DU (KR)
JUNG SEUNG HYUN (KR)
AHN YOUNG GIL (KR)
Application Number:
PCT/KR2017/006849
Publication Date:
January 04, 2018
Filing Date:
June 28, 2017
Export Citation:
Assignee:
HANMI PHARMACEUTICAL CO LTD (KR)
International Classes:
C07D487/14; A61K9/20; A61K9/48; A61K31/519; C07D471/14
Domestic Patent References:
WO2014172425A1 | 2014-10-23 | |||
WO2001029042A1 | 2001-04-26 |
Foreign References:
KR20040099384A | 2004-11-26 | |||
US20140088100A1 | 2014-03-27 |
Other References:
CHEN, P. ET AL.: "Imidazoquinoxaline Src-family Kinase p56Lck Inhibitors: SAR, QSAR, and the Discovery of (S)-N-(2-chloro-6-methylphenyl)-2- (3-methyl-1-piperazinyl) Imidazo-[l, 5-a] Pyrido [3, 2-e] Pyrazin-6-Amine (BMS-279700) as a Potent and Orally Active Inhibitor with Excellent in Vivo Antiinflammatory Activity", JOURNAL OF MEDICINAL CHEMISTRY, vol. 47, no. 18, 2004, pages 4517 - 4529, XP002449285
See also references of EP 3476846A4
DAILEY ET AL., CYTOKINE GROWTH FACTOR REV., vol. 16, pages 233 - 247
ESWARAKUMAR ET AL., CYTOKINE GROWTH FACTOR REV., vol. 16, pages 139 - 149
OZAWA ET AL., TERATOG. CARCINOG. MUTAGEN., vol. 21, 2001, pages 27 - 44
DIECI ET AL., CANCER DISCOVERY, 2013, pages OF 1 - OF 16
WESCHE ET AL., BIOCHEM J, vol. 437, 2011, pages 199 - 213
S. MIURA ET AL., BMC CANCER, vol. 12, 2012, pages 1471 - 2407
BANGE ET AL., CANCER RES., vol. 62, 2002, pages 840 - 847
J. MED. CHEM., vol. 48, 2005, pages 4628 - 4653
See also references of EP 3476846A4
DAILEY ET AL., CYTOKINE GROWTH FACTOR REV., vol. 16, pages 233 - 247
ESWARAKUMAR ET AL., CYTOKINE GROWTH FACTOR REV., vol. 16, pages 139 - 149
OZAWA ET AL., TERATOG. CARCINOG. MUTAGEN., vol. 21, 2001, pages 27 - 44
DIECI ET AL., CANCER DISCOVERY, 2013, pages OF 1 - OF 16
WESCHE ET AL., BIOCHEM J, vol. 437, 2011, pages 199 - 213
S. MIURA ET AL., BMC CANCER, vol. 12, 2012, pages 1471 - 2407
BANGE ET AL., CANCER RES., vol. 62, 2002, pages 840 - 847
J. MED. CHEM., vol. 48, 2005, pages 4628 - 4653
Attorney, Agent or Firm:
HONESTY & JR PARTNERS INTELLECTUAL PROPERTY LAW GROUP (KR)
Download PDF:
Previous Patent: BIOPLASTIC FILM, BUBBLE FILM, AND BUBBLE FILM PRODUCT USING SAME
Next Patent: METHOD FOR MANUFACTURING ION-CONDUCTING MEMBRANE
Next Patent: METHOD FOR MANUFACTURING ION-CONDUCTING MEMBRANE